Medistim ASA (OSTO:MEDIO) Interest Expense : kr-7.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medistim ASA's interest expense for the three months ended in Mar. 2024 was kr -5.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-7.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medistim ASA's Operating Income for the three months ended in Mar. 2024 was kr 32.1 Mil. Medistim ASA's Interest Expense for the three months ended in Mar. 2024 was kr -5.0 Mil. Medistim ASA's Interest Coverage for the quarter that ended in Mar. 2024 was 6.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medistim ASA Interest Expense Historical Data

The historical data trend for Medistim ASA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Interest Expense Chart

Medistim ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.44

-0.15

-0.18

-0.12

-0.15

Medistim ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-6.81	-2.03	-0.03	-0.10	-4.99

Medistim ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.1 Mil.

Medistim ASA (OSTO:MEDIO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medistim ASA's Interest Expense for the three months ended in Mar. 2024 was kr-5.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr32.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was kr9.1 Mil.

Medistim ASA's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	32.068	/	-4.987
	=	6.43

The higher the ratio, the stronger the company's financial strength is.

Medistim ASA (OSTO:MEDIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MEDI:Norway MD1:Germany

Address

Okernveien 94, Oslo, NOR, 0579

Website

https://www.medistim.com

Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines